- Veterinary antimicrobial susceptibility testing (AST), which determines the most effective antibiotic treatment for infections in animals, is becoming an increasingly critical component of veterinary diagnostics in both livestock and companion animal sectors due to growing concerns over antimicrobial resistance and the need for targeted therapy
- The escalating demand for veterinary AST is primarily fueled by increasing regulatory initiatives promoting responsible antimicrobial use in animals, growing awareness among veterinarians and pet owners, and the rising prevalence of zoonotic diseases and animal infections
- North America dominated the veterinary antimicrobial susceptibility testing market with the largest revenue share of 39.2% in 2024, characterized by a robust veterinary healthcare infrastructure, strong regulatory frameworks, and widespread adoption of advanced diagnostic technologies, particularly in the United States where stringent monitoring of antimicrobial usage in livestock drives market expansion
- Asia-Pacific is expected to be the fastest growing region in the veterinary antimicrobial susceptibility testing market during the forecast period due to expanding veterinary services, increasing livestock production, and rising awareness of antimicrobial stewardship
- The disks and plate segment dominated the veterinary antimicrobial susceptibility testing market with a market share of 42.1% in 2024, driven by its cost-effectiveness, ease of use, and widespread acceptance in clinical veterinary settings for evaluating bacterial resistance patterns
